Regenxbio: Q2 Earnings Snapshot
ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Wednesday reported a loss of $68.2 million in its second quarter.
The Rockville, Maryland-based company said it had a loss of $1.58 per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.44 per share.
The biotechnology company posted revenue of $32.6 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $26 million.